FDA Unveils Medical Device “Postmarket Transformation”
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center is establishing a senior-level team of agency staffers and outside experts to lead an effort to revitalize the postmarket device safety program, the agency announced Jan. 19
You may also be interested in...
FDA postmarket transformation plan
A detailed report outlining implementation steps for CDRH's postmarket transformation initiative is due out in two weeks, said Susan Gardner, director, Office of Surveillance & Biometrics, during the Nov. 1 RAPS webcast. Announced in January, the four-point strategy aimed at enhancing the device center's surveillance techniques, focuses on agency collaboration, data sources and systems, risk communication, and compliance and enforcement (1"The Gray Sheet" Jan. 23, 2006, p. 5)...
FDA postmarket transformation plan
A detailed report outlining implementation steps for CDRH's postmarket transformation initiative is due out in two weeks, said Susan Gardner, director, Office of Surveillance & Biometrics, during the Nov. 1 RAPS webcast. Announced in January, the four-point strategy aimed at enhancing the device center's surveillance techniques, focuses on agency collaboration, data sources and systems, risk communication, and compliance and enforcement (1"The Gray Sheet" Jan. 23, 2006, p. 5)...
FDA And CMS Push, But Questions Linger Over Unique Device Identifiers
There were more questions than answers at an Oct. 25 FDA meeting to explore the creation of a unique device identifier system